MALAT1 and cervical carcinoma: Additionally, our research proposed the consideration whether specifically inactivating MALAT1 expression in cervical tumor via gene engineering tools could ameliorate mortality and morbidity of cervical carcinoma, or other cancers, providing more beneficial effects to improve the outcomes.